4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-18-031475
Chief Financial Officer bought 400 shares at $6.12 ($2,448)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bonner Michael Chief Financial Officer | 2018-05-17 | Purchase | +400 | $6.12 | $2,448 | 18,054 | D |
| Open-market purchases · 400 sh · avg $6.12 · $2,448 | |||||||
Loading xslF345X03/doc4.xml…